MlCRO-SCREENING AND SORTING APPARATUS, PROCESS, AND PRODUCTS
US-2019212332-A1 · Jul 11, 2019 · US
US12566124B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12566124-B2 |
| Application number | US-202117793879-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 27, 2021 |
| Priority date | Jan 27, 2020 |
| Publication date | Mar 3, 2026 |
| Grant date | Mar 3, 2026 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The disclosed apparatus, systems and methods relate to technology that provides a method for the assessment of the polymerization of a sample, e.g., whole blood or blood plasma coagulation, by a non-contact acoustic tweezing device via the application of a sweeping frequency to the levitating sample and the corresponding assessment of extracted sample parameters.
Opening claim text (preview).
The invention claimed is: 1 . A noncontact in vitro method of analyzing a sample, comprising: levitating the sample using an acoustic carrier signal at a first frequency; perturbing the sample using an acoustic modulation signal at one or more second frequencies; measuring the oscillations of the sample resulting from the acoustic modulation signal to obtain amplitude measurements against time; analyzing amplitude measurements against time to calculate an extracted parameter; and filtering the amplitude measurements with a bandpass filter, wherein one or more second frequencies is a single frequency. 2 . The noncontact in vitro method of claim 1 , further comprising: repeating one or more steps with a fluid of known viscosity, wherein the one or more steps are selected from a list consisting of levitating the sample using an acoustic carrier signal at a first frequency, perturbing the sample using an acoustic modulation signal at one or more second frequencies, measuring the oscillations of the sample resulting from the acoustic modulation signal to obtain amplitude measurements against time, analyzing amplitude measurements against time to calculate an extracted parameter, and filtering the amplitude measurements with a bandpass filter. 3 . The noncontact in vitro method of claim 1 , further comprising generating a calibration curve using the extracted parameters of a fluid of known viscosity. 4 . The noncontact in vitro method of claim 1 , further comprising estimating at least one characteristic of the sample by plotting its extracted parameter on a calibration curve. 5 . The noncontact in vitro method of claim 4 , wherein the at least one characteristic is viscosity. 6 . The noncontact in vitro method of claim 1 , wherein the one or more second frequencies be between about 1000 Hz to about 10 Hz. 7 . The noncontact in vitro method of claim 1 , wherein the one or more second frequencies be between about 150 Hz to about 50 Hz. 8 . The noncontact in vitro method of claim 1 , wherein the amplitude measurements against time are analyzed by generating an AFR curve from which the extracted parameters are calculated. 9 . The noncontact in vitro method of claim 8 , wherein the extracted parameter is area under the curve (AUC), peak frequency (fpeak), peak amplitude (Apeak), lowest frequency at half-frequency width (f1/2left), highest frequency at half-frequency width (f1/2right), minimum amplitude (Amin), maximum amplitude (Amin), quality factor (QF) and fpeak, the sum of several Apeaks, the bandwidth of instability, and/or the AUC of instability. 10 . The noncontact in vitro method of claim 9 , wherein the QF is calculated by dividing a resonant frequency of the AFR over a frequency range centered on the resonant frequency. 11 . The noncontact in vitro method of claim 10 , wherein the resonant frequency is the frequency at which a maximum amplitude of the AFR curve is observed. 12 . The noncontact in vitro method of claim 10 , wherein the frequency range is between about 30% to about 70% of the frequency at which a maximum amplitude is observed. 13 . The noncontact in vitro method of claim 1 , wherein the amplitude measurements against time are measured with a viscous tweezograph. 14 . The noncontact in vitro method of claim 1 , wherein the biological sample is whole blood or blood plasma.
White blood cells · CPC title
Red blood cells · CPC title
Elastic parameters, strength or force · CPC title
Density, viscosity · CPC title
Particle shape · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.